Shows / This Week In Medicine
This Week In Medicine
Welcome to This Week in Medicine - Your Filtered Medical Journal SummaryLooking to stay up-to-date with the latest medical research but short on time? This Week in Medicine has you covered!Our AI generated podcast provides you with a convenient, on-the-go solution to keep you informed about the most significant developments in the medicine field. We understand that your time is valuable, so we've done the hard work for you.Each episode offers a filtered and concentrated summary of key journal…
Episodes
- This Week In Medicine
NEJM June 2028 Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection
This text details a medical breakthrough involving bepirovirsen, an innovative antisense oligonucleotide designed to treat chronic hepatitis B. Through two…
- This Week In Medicine
JAMA June 2026 Prior Traumatic Brain Injury and Alzheimer Disease Blood Biomarkers Importance
This study investigates whether a history of traumatic brain injury (TBI) affects the reliability of modern blood-based biomarkers used to diagnose Alzheimer’s…
- This Week In Medicine
JAMA June 2026 Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis The PARADIGM Randomized Clinical Trial.
The PARADIGM trial investigated the safety and clinical impact of PrimeC, a novel oral therapy designed to stabilize the biological pathways compromised by…
- This Week In Medicine
JAMA June 2026 Self-Directed vs Clinician-Delivered Cognitive Behavioral Therapy for Chronic Pain A Randomized Clinical Trial.
This study explores a modern solution to the barriers of chronic pain management by comparing self-directed cognitive behavioral therapy (CBT) against…
- This Week In Medicine
NEJM June 2026 Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection.
This clinical report evaluates the efficacy of bepirovirsen, an innovative antisense oligonucleotide designed to achieve a functional cure for chronic…
- This Week In Medicine
May 2026 Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cance
This study evaluates the clinical potential of daraxonrasib, a novel oral medication designed to inhibit the RAS mutations that drive growth in over 90% of…
- This Week In Medicine
NEJM May 2026 Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention
This study investigated whether using a microaxial flow pump to assist the heart during complex arterial procedures offers a clinical advantage for patients…
- This Week In Medicine
NEJM 4 2026 Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.
This clinical study explores the efficacy of Mim8, a novel subcutaneous treatment designed to imitate the function of a vital clotting protein in patients with…
- This Week In Medicine
NEJM 4 2026 A Multicomponent Intervention to Improve Maternal Infection Outcomes
To address the high rate of preventable deaths in low-resource settings, researchers tested a comprehensive medical program known as APT-Sepsisto improve how…
- This Week In Medicine
NEJM April 2026 First-Line Zongertinib in Advanced HER2-Mutant Non–Small-Cell Lung Cancer
This clinical study explores the impact of zongertinib, an innovative oral medication designed to treat a specific subtype of advanced lung cancercharacterized…
- This Week In Medicine
NEJM 4 23 2026 Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.
This study explores the effectiveness of transdermal estradiol patchesas a modern alternative to traditional hormone therapy for managing advanced prostate…
- This Week In Medicine
NEJM 4 23 2206 Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients.
This study investigates whether the antiviral treatment nirmatrelvir–ritonavir provides significant clinical benefits to vaccinated individuals at high risk…
- This Week In Medicine
NEJM 4 23 2026: Three Low-Dose Antihypertensive Agents in a Single Pill after Intracerebral Hemorrhage
This study explores a novel strategy for preventing recurrent strokes in patients who have previously suffered from brain bleeds by utilizing a single pill…
- This Week In Medicine
JAMA 4 2026 Cost-Effectiveness of ApoB, Non–HDL-C, and LDL-C Goals for Primary Prevention Lipid-Lowering Therapy.
This study utilized computer simulations to evaluate whether monitoring Apolipoprotein B (apoB) is a more efficient and affordable way to prevent heart disease…
- This Week In Medicine
JAMA 4 2026 Colorectal Cancer and Mortality Risk Among Older Adults With vs Without Adenoma on Prior Colonoscopy
This study investigated whether older adults who previously had benign growths called adenomas were at a higher risk for developing colorectal cancer compared…
- This Week In Medicine
JAMA 4 2026 Real-World Outcomes of Transcatheter Tricuspid Valve Replacement Analysis From the STS/ACC TVT Registry
This study investigates the real-world safety and effectiveness of transcatheter tricuspid valve replacement (TTVR) for patients suffering from severe heart…
- This Week In Medicine
NEJM 4 2026 Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
This study evaluates whether patients with stable heart function can safely stop taking long-term beta-blocker therapy after recovering from a heart attack…
- This Week In Medicine
NEJM 4 2026 eft Atrial Appendage Closure or Medical Therapy in Atrial Fibrillation
This study evaluates whether a mechanical procedure to seal the heart's left atrial appendage is as effective as standard drug treatments for preventing…
- This Week In Medicine
NEJM 4 2026 Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
This study investigated whether pushing LDL cholesterol levels even lower than current standard targets provides better protection for people already living…
- This Week In Medicine
NEJM 4 2026 Multifaceted Strategies for Hypertension Control in Low-Income Patients
This study investigates how a multifaceted, team-based approach can effectively lower blood pressure among low-income and minority populations who face…
- This Week In Medicine
NEJM 4 2026 Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
This study evaluates a new treatment strategy for patients with muscle-invasive bladder cancer who cannot undergo standard cisplatin chemotherapy, a group…
- This Week In Medicine
NEJM 3 26 26 Dengue Suppression by Male Wolbachia-Infected Mosquitoes.
This research study explores a biological method for controlling dengue fever in Singapore by releasing specially infected male mosquitoes into the…
- This Week In Medicine
NEJM 3 26 26 Early Surgery or Conservative Care for Asymptomatic Aortic Stenosis at 10 Years
This study investigates whether proactive medical intervention or watchful waiting provides better long-term outcomes for patients with severe aortic stenosis…
- This Week In Medicine
NEJM 3 26 26 Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
his clinical study investigates whether adding the immunotherapy drug atezolizumab to standard chemotherapy significantly benefits patients recovering from…
- This Week In Medicine
Lancet March 2026 Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study
This international study investigates the clinical landscape for immunocompromised individuals suffering from acute respiratory failure, a primary driver of…
- This Week In Medicine
Lancet March 2026 The effectiveness of HPV vaccination against invasive cervical cancer and related precancerous lesions: a multinational target trial emulation study
By analyzing extensive healthcare data from the United Kingdom, Spain, and Norway, this study evaluates how well HPV vaccination programs protect young women…
- This Week In Medicine
NEJM March 12 2026 Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
This study evaluates whether time-limited drug combinations are as effective as lifelong daily medication for patients newly diagnosed with chronic lymphocytic…
- This Week In Medicine
NEJM March 12 2026 Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
This study investigates the effectiveness of the drug romiplostim in managing a frequent cancer treatment complication where chemotherapy causes a dangerous…
- This Week In Medicine
NEJM March 12 2026 Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism
This clinical study investigates the safety profiles of two common blood thinners by comparing their potential to cause harmful side effects during the…
- This Week In Medicine
JAMA Pediatrics March 2026 Screen Use at Bedtime and Sleep Duration and Quality Among Youths
This study utilized objective video monitoring and wearable sensors to move beyond unreliable self-reporting when investigating how adolescent technology use…
- This Week In Medicine
NEJM March 5 2026 Immediate or Deferred Nonculprit-Lesion PCI in Myocardial Infarction
This study investigated whether the timing and method of treating secondary arterial blockages in heart attack patients affects their long-term recovery…
- This Week In Medicine
NEJM March 5 2026 Finerenone in Type 1 Diabetes and Chronic Kidney Disease
This clinical study investigates whether the drug finerenone can help protect the kidneys of adults living with type 1 diabetes, a population for whom the…
- This Week In Medicine
JAMA February 2026 Coffee and Tea Intake, Dementia Risk, and Cognitive Function
This extensive longitudinal study tracked over 130,000 individuals for more than four decades to clarify how different hot beverages impact long-term brain…
- This Week In Medicine
JAMA February 2026 Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation
This clinical study investigated the most effective way to manage multiple brain metastases by comparing highly targeted stereotactic radiationagainst a…
- This Week In Medicine
JAMA February 2026 Worldwide Radiation Dose in Coronary Artery Disease Diagnostic Imaging
This global study examines the ionizing radiation exposure that patients experience during common medical imaging procedures used to diagnose heart disease. By…
- This Week In Medicine
NEJM February 2026 Tecovirimat for the Treatment of Mpox
This clinical study investigated whether the drug tecovirimat, originally approved for smallpox based on animal data, effectively treats human clade II mpox…
- This Week In Medicine
NEJM February 2026 Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
This study investigates whether a long-acting injectable treatment is more effective than traditional daily pills for HIV patients who struggle with medication…
- This Week In Medicine
NEJM February 2026 Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
This clinical study evaluates a promising medical advancement for patients with HER2-positive breast cancer who still have signs of the disease following their…
- This Week In Medicine
Lancet February 2026 Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence B
Source guide This meta-analysis explores the invasiveness of various pneumococcal serotypes by comparing how often they live harmlessly in the throat versus…
- This Week In Medicine
Lancet February 2026 End-to-end integrative segmentation and radiomics prognostic models for risk stratification of high-grade serous ovarian cancer: a retrospective multicohort study
Researchers have developed an innovative artificial intelligence pipelinedesigned to automate the analysis of medical imaging for patients with high-grade…
- This Week In Medicine
Lancet February 2026 Zegocractin for acute pancreatitis with systemic inflammatory response syndrome: a randomized, controlled, dose-ranging, phase 2b trial
This clinical study investigated the efficacy of zegocractin, a novel drug designed to treat acute pancreatitis by blocking specific calcium channels to reduce…
- This Week In Medicine
NEJM February 19 2026 An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
This study investigates a novel medical treatment called del-desiran, an innovative therapy designed to combat myotonic dystrophy type 1 by targeting the…
- This Week In Medicine
NEJM February 19 2026 Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma
This clinical study evaluates the effectiveness of combining two targeted immunotherapies, teclistamab and daratumumab, to treat patients with multiple myeloma…
- This Week In Medicine
JAMA February 5 Tenecteplase for Acute Non–Large Vessel Occlusion 4.5 to 24 Hours After Ischemic Stroke
The OPTION trial investigated whether the clot-dissolving drug tenecteplase could improve recovery for stroke patients who arrived at the hospital between 4.5…
- This Week In Medicine
JAMA February 11 Coffee and Tea Intake, Dementia Risk, and Cognitive Function.
This extensive longitudinal study tracked over 130,000 individuals for more than four decades to determine how beverage choices influence brain health as we…
- This Week In Medicine
JAMA February 11 Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
This study investigates whether a seven-day injectable dose of medication-assisted treatment in the emergency department is more effective than the standard…
- This Week In Medicine
NEJM February 2026 Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
This clinical study evaluated whether patients with atrial fibrillation who have lived with a drug-eluting stent for at least one year should take a single…
- This Week In Medicine
NEJM February 2026 A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
This scientific report details a significant medical study on a new treatment for IgA nephropathy, a common and dangerous kidney disease driven by abnormal…
- This Week In Medicine
NEJM February 2026 Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial
monoclonal antibody designed to block a protein called APRIL that fuels the progression of IgA nephropathy. By neutralizing this key driver, the drug aims to…
- This Week In Medicine
Lancet February 2026 Smartwatch-derived versus self-reported outcomes of physiological recovery after COVID-19, influenza, and group A streptococcus: a 2-year prospective cohort study
This research investigates the discrepancy between how patients feel and how their bodies actually function after an illness, using smartwatch datato track…
- This Week In Medicine
Lancet February 2026, Delirium and adverse clinical outcomes: a matched cohort study in the UK Biobank
This research study reveals that experiencing delirium during a hospital stay acts as a sentinel event, signaling a widespread and long-term multisystem…
- This Week In Medicine
NEJM February 5,2026 Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
This clinical study investigates whether a novel drug combination can improve outcomes for patients facing HER2-positive metastatic breast cancer who have not…
- This Week In Medicine
NEJM February 5,2026 Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.
This meta-analysis investigated whether prescribing beta-blockersprovides any clinical benefit to heart attack survivors who maintain a normal ejection…
- This Week In Medicine
NEJM February 5,2026:A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide
This study examines the effectiveness of enlicitide, a novel oral PCSK9 inhibitor, in treating patients with a genetic predisposition for dangerously high…
- This Week In Medicine
American Journal of HTN January 2026 Trends in Initial Combination Antihypertensive Therapy in a US Health System
Source guide This study examines a concerning shift in medical practice by tracking how often doctors prescribe multiple medications simultaneously to treat…
- This Week In Medicine
JAMA Network Open ID Single-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital
This research study evaluates a streamlined treatment method for cryptococcal meningitis, a dangerous fungal brain infection that frequently affects…
- This Week In Medicine
NEJM January 28, 2026: A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D
This research study evaluates the effectiveness of two experimental drugs, tobevibart and elebsiran, in treating chronic hepatitis D, a serious viral…
- This Week In Medicine
NEJM January 28,2026 Nivolumab for Resected Stage III or IV Melanoma at 9 Years
The provided text details the long-term results of the CheckMate 238 clinical trial, which evaluated the effectiveness of two immunotherapy drugs in preventing…
- This Week In Medicine
NEJM January 28,2026 Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
This clinical study investigates whether patients who have undergone a successful catheter ablation for atrial fibrillation still require powerful…
- This Week In Medicine
NEJM January 22,2026 Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
This clinical study investigates a promising new treatment combination for patients facing advanced triple-negative breast cancer, a particularly aggressive…